Bel/Bael

Aegle marmelos
Bel/Bael (Aegle marmelos), a significant fruit in Ayurveda, is traditionally used for its supposed ability to balance Vata, Pitta, and Kapha doshas. This native Indian tree is prevalent for its claimed digestive and overall health benefits, with various parts like the fruit, root, and bark commonly utilized in traditional formulations.
PLANT FAMILY
Rutaceae (Rue)
PARTS USED
Fruit, Root, Bark
AYURVEDIC ACTION
Vata ↓, Pitta ↓, Kapha ↓
ACTIVE COMPOUNDS
Marmelosin (0.1-0.5%)

What is Bel/Bael?

Bel, also known as Bael, is the fruit of the Aegle marmelos tree, a species native to the Indian subcontinent. Belonging to the Rutaceae family, it's a medium-sized tree with a hard, woody fruit that ripens to a yellowish-orange color. The fruit's pulp is aromatic and has a sweet, sometimes tangy, taste.

Beyond its culinary use, various parts of the Bel tree, including its fruit, roots, and bark, have been traditionally utilized for their medicinal properties in Ayurvedic and other traditional systems.

Other Names of Bel/Bael

  • Wood Apple
  • Stone Apple
  • Bengal Quince
  • Indian Bael
  • Bilva
Aikya Linga in Varanasi

Benefits of Bel/Bael

Heading

<h3> Absolute Contraindications of Bel/Bael </h3> <h4> Pregnancy / Early Pregnancy (risk of miscarriage) [In layman terms]</h4> <ul> <li> 🤰 <li> Recommendation: Avoid using bel extracts or concentrated bael leaf/ bark preparations during pregnancy; consult your healthcare provider if you have used them. Fresh fruit in small culinary amounts is different, but medicinal doses should be avoided. <li> Reasoning: Animal experiments with certain ethanolic leaf extracts and specific preparations have produced reduced fetal survival and increased abortion rates at experimental doses, indicating that some bael constituents can impair embryo/fetal viability in animal models. <li> Scientific_Study_Title: Abortifacient activity of Aegle marmelos and Laurus nobilis leaf extracts. <li> Scientific_Study_Authors: (authors as listed on the paper) - see paper for full author list. <li> Scientific_Study_Link: https://www.pagepress.org/journals/index.php/pcr/article/view/9657 <li> Scientific_Study_Excerpt: <p>In controlled experiments on rats dosed orally with ethanolic Aegle marmelos leaf extract during early pregnancy, treated groups showed a dose-related reduction in the number of live fetuses and increased rates of fetal loss compared to vehicle controls. Survival ratios decreased substantially as dose rose, and abortion rates were higher at the larger dose. The authors concluded that ethanolic leaf extract produced significant negative effects on fetal survival in this model, recommending caution and further study before recommending use in pregnancy.</p> <p>This animal evidence supports avoiding medicinal-strength bael preparations during pregnancy because effects on human pregnancy are not well studied and potential risk exists.</p> </ul> <h4> Known active liver disease or prior herb/dietary-supplement-related liver injury [In layman terms]</h4> <ul> <li> 🩺🧪 <li> Recommendation: Do not use bael extracts if you have active hepatitis, unexplained jaundice, or a history of herb/supplement-related liver injury; seek medical advice before taking any bael product. <li> Reasoning: Products containing aegeline (a bael constituent or its synthetic analogue) have been linked to clinically significant acute liver injury in humans; this indicates that concentrated extracts or aegeline-containing supplements can pose real liver risk in some cases. <li> Scientific_Study_Title: OxyELITE Pro - clinical reports and LiverTox summary of acute liver injury associated with a supplement containing aegeline. <li> Scientific_Study_Authors: US National Institutes of Health - LiverTox / multiple clinical investigators covered in the review. <li> Scientific_Study_Link: https://www.ncbi.nlm.nih.gov/books/NBK548935/ <li> Scientific_Study_Excerpt: <p>Clinical surveillance identified a cluster of severe acute hepatitis cases temporally associated with use of OxyELITE Pro, a multi-ingredient dietary supplement that contained aegeline (a compound related to constituents of Aegle marmelos). Affected patients developed marked aminotransferase elevations, jaundice and in some cases acute liver failure requiring transplantation or causing death. Liver biopsies showed acute hepatitis-like injury; the pattern and timing implicated the supplement. The LiverTox review attributes the hepatic outbreak to aegeline (or contaminants in the added synthetic ingredient) and documents that supplement-associated acute hepatotoxicity can be severe.</p> <p>The clinical report underlines that concentrated aegeline exposure (as found in some supplements) can cause severe, sometimes life-threatening liver injury - hence bael extracts should not be used by people with active liver disease or prior supplement-related liver problems.</p> </ul> <h4> Concurrent use with critical drugs primarily cleared by CYP3A4 or CYP1A2 where dose control is essential [In layman terms]</h4> <ul> <li> ⚠️💊 <li> Recommendation: Do NOT take bael extracts together with medications that have a narrow therapeutic window (e.g., certain statins, anti-rejection drugs, some benzodiazepines) without physician/pharmacist approval and monitoring. <li> Reasoning: Laboratory studies show bael fruit constituents can inhibit key liver enzymes (CYP3A4 and CYP1A2). Inhibition of these enzymes can raise blood levels of drugs cleared by them, increasing toxicity risk for narrow-index medicines. <li> Scientific_Study_Title: Inhibition of CYP3A4 and CYP1A2 by Aegle marmelos and its constituents. <li> Scientific_Study_Authors: (authors as listed on the PubMed entry) <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/26247834/ <li> Scientific_Study_Excerpt: <p>In vitro experiments using human liver microsomes and recombinant CYP enzymes examined methanolic extracts of Aegle marmelos fruit and isolated constituents (marmelosin, marmesinin, 8-hydroxypsoralen, aegeline). The extract and marmelosin exhibited competitive and time-dependent inhibition of CYP3A4 and reversible inhibition of CYP1A2. This suggests that clinically relevant bael preparations could reduce clearance of drugs metabolized by these enzymes, leading to higher systemic drug levels and potential adverse effects, particularly for medications with a narrow therapeutic index.</p> <p>Based on these enzyme inhibition data, coadministration with critical CYP3A4/CYP1A2 substrates should be considered contraindicated unless supervised and monitored by clinicians.</p> </ul> <h3> Relative Contraindications of Bel/Bael </h3> <h4> People already taking blood-glucose-lowering medicines (insulin, sulfonylureas, metformin when combined) [In layman terms]</h4> <ul> <li> 🩸🍬 <li> Recommendation: Use bael preparations with caution if you are on diabetes drugs; monitor blood sugar closely and consult your clinician - dosage adjustments may be required. <li> Reasoning: Multiple animal studies show bael extracts lower blood glucose and improve glycaemic markers; when combined with antidiabetic drugs, these effects can be additive, increasing the chance of hypoglycaemia. <li> Scientific_Study_Title: Hypoglycaemic effect of water extracts of Aegle marmelos fruits in streptozotocin diabetic rats. <li> Scientific_Study_Authors: (authors as given in the PubMed record) <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/12860309/ <li> Scientific_Study_Excerpt: <p>Oral administration of aqueous fruit extract to streptozotocin-induced diabetic rats (125-250 mg/kg twice daily for 4 weeks) produced significant reductions in blood glucose and markers of oxidative stress, with improvements in plasma reduced glutathione and vitamin C. The 250 mg/kg dose in animals was more effective than glibenclamide in restoring several biochemical parameters linked to diabetes. The study demonstrates pronounced antihyperglycaemic and antioxidant effects in experimental diabetes models, suggesting potential for additive glucose-lowering when used alongside prescribed antidiabetic therapy.</p> </ul> <h4> Men actively trying to conceive (fertility concerns) [In layman terms]</h4> <ul> <li> 👨‍👩‍👧‍👦⚠️ <li> Recommendation: Men planning conception should avoid high-dose bael bark/leaf extracts until more safety data are available; discuss use with a clinician. <li> Reasoning: Experimental studies in male rats using methanolic bark extract produced reversible infertility (reduced sperm count, motility and testicular changes) after repeated dosing; although reversible on withdrawal, this suggests a potential contraceptive effect at pharmacologic doses. <li> Scientific_Study_Title: Antifertility activity of methanolic bark extract of Aegle marmelos (L.) in male Wistar rats. <li> Scientific_Study_Authors: (authors as listed on the PubMed entry) <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/23351957/ <li> Scientific_Study_Excerpt: <p>Male rats treated with methanolic bark extract (200-600 mg/kg daily for 60 days) showed dose- and time-dependent reductions in reproductive organ weights, serum testosterone, sperm density, motility and viability, and histopathological testicular changes consistent with impaired spermatogenesis. Following withdrawal, many parameters gradually recovered, indicating reversible antifertility effects. The study suggests that bark extracts at experimental doses can significantly reduce male fertility in animals, warranting caution for men intending conception.</p> </ul> <h4> Use in children and in situations with limited human safety data [In layman terms]</h4> <ul> <li> 🧒❗ <li> Recommendation: Use caution with medicinal-strength bael products in young children; consult a pediatrician before giving concentrated extracts - traditional culinary use of ripe fruit is different and generally tolerated in small food amounts. <li> Reasoning: While some traditional uses involve children for diarrhoea, formal reproductive and safety testing is limited; one reproduction study in female rats showed no effect at tested concentrations, but comprehensive pediatric safety data are lacking. <li> Scientific_Study_Title: Safety evaluation of aqueous extracts from Aegle marmelos and Stevia rebaudiana on reproduction of female rats. <li> Scientific_Study_Authors: (authors as in PubMed) <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/17547081/ <li> Scientific_Study_Excerpt: <p>In this study female Wistar rats treated with 6% aqueous Aegle marmelos extract (1 mL/day for 60 days) prior to mating showed no significant differences in numbers of corpus lutea, implanted or dead fetuses or fetal size at day 14 of pregnancy compared to controls. The authors concluded that at the tested concentrations the extract did not alter female reproductive parameters in rats. However, the paper also highlights that safety findings in animals at particular doses cannot be directly equated to all human dosing regimens, so pediatric use of concentrated extracts should be cautious and supervised.</p> </ul>

Heading

<h4> Liver injury / hepatotoxicity (yellowing, fatigue, high liver enzymes) </h4> <ul> <li> 🟡🩸 <li> Side effect summary: Some concentrated bael constituents, notably aegeline (or synthetic analogues used in supplements), have been linked to acute liver injury in humans and show metabolic pathways that can form reactive metabolites in lab studies. <li> Recommendation: Stop the herb if you develop jaundice, dark urine, severe fatigue or abdominal pain; seek immediate medical care. Avoid concentrated supplements containing aegeline. <li> Reasoning: In vitro and animal metabolic studies show aegeline can be bioactivated by drug-metabolising enzymes (notably CYP2C19) to reactive metabolites; clinical reports associate aegeline-containing supplements with acute liver failure cases. <li> Severity Level: Severe <li> Scientific_Study_Available: Yes <li> Scientific_Study_Title: Metabolic activation of aegeline mediated by CYP2C19. <li> Scientific_Study_Authors: (authors as listed in PubMed) <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/33892609/ <li> Scientific_Study_Excerpt: <p>Laboratory investigations identified demethylated and glutathione-conjugated metabolites of aegeline in liver microsomal and hepatocyte systems; recombinant enzyme studies showed CYP2C19 as a principal catalyst of this bioactivation. The GSH-conjugate detection indicates formation of reactive electrophilic metabolites capable of covalent binding, a common mechanism underlying chemical-induced hepatocellular injury. Blocking CYP2C19 reduced formation of these metabolites and attenuated hepatocyte cytotoxicity in vitro, supporting a metabolism-dependent pathway to liver injury.</p> <p>The study provides mechanistic evidence linking aegeline metabolism to reactive metabolites and cellular toxicity and supports clinical observations of herb/supplement-associated liver injury when aegeline exposure is high.</p> </ul> <h4> Symptomatic hypoglycaemia when combined with diabetes medicines (shakiness, sweating, dizziness) </h4> <ul> <li> 😰🍭 <li> Side effect summary: Bael extracts lower blood glucose in animal models; when combined with prescribed antidiabetic drugs the combined effect may produce low blood sugars. <li> Recommendation: If you have diabetes and take bael alongside antidiabetic medicines, check blood glucose more often and discuss dose adjustments with your clinician; in case of severe hypoglycaemia, seek emergency care. <li> Reasoning: Multiple preclinical studies demonstrate significant glucose reduction with fruit/seed/leaf extracts; additive or synergistic lowering can occur with pharmaceuticals. <li> Severity Level: Moderate <li> Scientific_Study_Available: Yes <li> Scientific_Study_Title: Hypoglycemic and antihyperglycemic activity of Aegle marmelos seed extract in normal and diabetic rats. <li> Scientific_Study_Authors: (authors listed in PubMed record) <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/16781099/ <li> Scientific_Study_Excerpt: <p>Aqueous seed extract administered orally produced dose-dependent reductions in blood glucose in normal, glucose-tolerant and diabetic rat models, with marked decreases in fasting blood glucose and urine sugar in severely diabetic animals after repeated dosing. The extract also improved lipid profiles (lowered LDL and triglycerides, raised HDL). These pronounced blood glucose changes in experimental animals indicate that co-use with other glucose-lowering agents could increase the risk of clinically important hypoglycaemia.</p> </ul> <h4> Constipation or stool hardening if overused (especially unripe/over-concentrated forms) </h4> <ul> <li> 🚽🔒 <li> Side effect summary: The astringent (grahi) action of unripe bael can excessively bind stool leading to constipation if used inappropriately or in overly concentrated doses. <li> Recommendation: Use the correct form and dose for the problem (unripe pulp is classically used to stop diarrhoea; ripe fruit and balanced formulations are used when nourishment is needed). If constipation develops, stop the preparation and seek guidance. <li> Reasoning: Antidiarrhoeal studies show bael’s ability to reduce stool liquidity and bind intestinal contents - a useful effect in diarrhoea, but the same properties can cause unwanted stool hardening if unrestricted use or high doses are taken. <li> Severity Level: Mild <li> Scientific_Study_Available: Yes <li> Scientific_Study_Title: Studies on the antidiarrhoeal activity of Aegle marmelos unripe fruit: validating its traditional usage. <li> Scientific_Study_Authors: (see PubMed entry) <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/19930633/ <li> Scientific_Study_Excerpt: <p>The decoction of dried unripe fruit pulp demonstrated effects on bacterial colonization, enterotoxin production and binding, and had antigiardial and antirotaviral activities; while not broadly bactericidal, the preparation reduced colonization and lowered stool secretion in models of infectious diarrhoea. These 'binding' (grahi) and anti-secretory actions explain its classical use to stop diarrhoea but also imply a risk of constipation when used in excess or outside appropriate clinical indication.</p> </ul>

Heading

<h4> Oral hypoglycemic agents / Insulin</h4> <ul> <li> Interaction_Details: Bael extracts lower blood glucose in preclinical models; combining with insulin, sulfonylureas, or other hypoglycemics may produce additive blood-glucose lowering and hypoglycemia. <li> Severity: Moderate <li> Recommendation: Monitor blood glucose closely and inform your prescribing clinician before combining; dose reductions of antidiabetic drugs may be needed under medical supervision. <li> Scientific_Study_Available: Yes <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/12860309/ <li> Scientific_Study_Title: Hypoglycaemic effect of water extracts of Aegle marmelos fruits in streptozotocin diabetic rats. <li> Scientfic_Study_Authors: (authors as listed in PubMed) <li> Scientific_Study_Excerpt: <p>In streptozotocin-induced diabetic rats, oral administration of aqueous bael fruit extract significantly reduced blood glucose and improved antioxidant markers; at higher doses the extract was even more effective than glibenclamide for certain biochemical endpoints. Such clear hypoglycaemic activity in animal models indicates a realistic potential for additive blood sugar lowering when bael is taken alongside prescribed antidiabetic medicines, necessitating monitoring and clinician guidance.</p> </ul> <h4> Drugs primarily metabolized by CYP3A4 (examples: certain statins like simvastatin, calcineurin inhibitors like tacrolimus, some benzodiazepines)</h4> <ul> <li> Interaction_Details: Bael fruit constituents (e.g., marmelosin) can inhibit CYP3A4 activity in vitro; coadministration may raise blood levels of CYP3A4 substrates and increase adverse effects. <li> Severity: Severe (for narrow-index drugs) <li> Recommendation: Avoid combining concentrated bael extracts with critical CYP3A4 substrates, or do so only with specialist oversight and therapeutic drug monitoring where available. <li> Scientific_Study_Available: Yes <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/26247834/ <li> Scientific_Study_Title: Inhibition of CYP3A4 and CYP1A2 by Aegle marmelos and its constituents. <li> Scientfic_Study_Authors: (authors listed on the PubMed entry) <li> Scientific_Study_Excerpt: <p>Using human liver microsomes and recombinant enzymes, the methanolic extract of Aegle marmelos and marmelosin showed competitive and time-dependent inhibition of CYP3A4 and reversible inhibition of CYP1A2. Given CYP3A4's central role in clearing many prescription drugs, these in vitro findings indicate the potential for clinically meaningful increases in blood concentrations of susceptible drugs, especially those with narrow therapeutic windows - a mechanism consistent with herb-drug interaction risk.</p> </ul> <h4> Drugs/prodrugs where CYP2C19 activity is critical (example: clopidogrel activation) and Drugs metabolically interacting with aegeline</h4> <ul> <li> Interaction_Details: Aegeline can be bioactivated by CYP2C19; competition for or induction/inhibition of CYP2C19-mediated pathways may alter activation or clearance of other drugs processed by this enzyme. <li> Severity: Moderate <li> Recommendation: Consult a clinician before using bael formulations if you take drugs where CYP2C19 activity is critical; consider monitoring and alternative therapies where appropriate. <li> Scientific_Study_Available: Yes <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/33892609/ <li> Scientific_Study_Title: Metabolic activation of aegeline mediated by CYP2C19. <li> Scientfic_Study_Authors: (authors as listed in PubMed) <li> Scientific_Study_Excerpt: <p>Investigators identified demethylated and glutathione-conjugated metabolites of aegeline in liver incubations and animal samples, and recombinant P450 studies implicated CYP2C19 as a principal enzyme catalysing this bioactivation. Inhibition of CYP2C19 reduced formation of reactive metabolites and attenuated cell toxicity in hepatocyte models. These data imply that aegeline both uses and affects CYP2C19 pathways; therefore coadministration with drugs relying on that enzyme for activation or clearance could lead to altered drug effects or metabolite formation.</p> </ul> <h4> Concurrent use with other hepatotoxic agents (example: high-dose acetaminophen, certain statins, or hepatotoxic supplements)</h4> <ul> <li> Interaction_Details: Because aegeline and some bael constituents can produce reactive metabolites and have been associated with liver injury, combining bael extracts with other hepatotoxic agents may increase cumulative liver risk. <li> Severity: Severe <li> Recommendation: Avoid combined use of concentrated bael products with known hepatotoxins; if unavoidable, perform close liver function monitoring under medical supervision. <li> Scientific_Study_Available: Yes <li> Scientific_Study_Link: https://www.ncbi.nlm.nih.gov/books/NBK548935/ <li> Scientific_Study_Title: OxyELITE Pro - LiverTox (NIH) - clinical report and summary of acute liver injury associated with an aegeline-containing supplement. <li> Scientfic_Study_Authors: NIH LiverTox / investigators summarized in the article <li> Scientific_Study_Excerpt: <p>The LiverTox summary details cases of acute severe hepatocellular injury linked to OxyELITE Pro after aegeline was introduced; clinical features ranged from fatigue and nausea to marked jaundice and very high transaminases, with some cases progressing to liver failure and transplantation. The outbreak emphasizes that concentrated aegeline exposure-especially in multi-ingredient supplements-can produce severe liver injury, and that combining such exposure with other hepatotoxic agents could increase the risk or severity of liver damage.</p> </ul>